Showing results (131-140 of 523) with videos related to

Sort By:
Pageof 53
Annals of Surgical Oncology|February 11, 2026
Long-Term Results of Multiple Pulmonary MetastasectomiesMichele Ferrari, Camilla Valsecchi, Giovanni Leuzzi, et al.
Scientific Reports|October 10, 2023
Routine perioperative blood tests predict survival of resectable lung cancerDaniele Morelli, Anna Cantarutti, Camilla Valsecchi, et al.
Future Oncology (London, England)|January 16, 2016
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkersFrancesca Maines, Orazio Caffo, Davide Donner, et al.
Experimental and Molecular Pathology|February 27, 2017
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysisAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.
Expert Review of Anticancer Therapy|June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysisChiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.
Cancers|April 12, 2022
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-AnalysisFederica Galiandro, Salvatore Agnes, Giovanni Moschetta, et al.
Anti-Cancer Drugs|September 1, 2007
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyCecilia Nisticò, Emilio Bria, Federica Cuppone, et al.
Seminars in Oncology|January 23, 2019
Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Expert Review of Anticancer Therapy|December 21, 2017
The development of PARP as a successful target for cancer therapyRoberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
Biomed Research International|June 28, 2014
CXC and CC chemokines as angiogenic modulators in nonhaematological tumorsMatteo Santoni, Sergio Bracarda, Massimo Nabissi, et al.
Pageof 53